AndrewGianoukakisMD

PubMed

• Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
  Choe, J., Babajanyan, S., Gianoukakis, A., Bowles, D., Owonikoko, T., Worden, F., Wirth, L., Brose, M.> ;European Thyroid Journal. 2024 Feb 1
• 1 citations
  Thyroglobulin Cutoff Values for Detecting Excellent Response to Therapy in Patients With Differentiated Thyroid Cancer.
  Jennifer A Sipos, Joseph Aloi, Andrew Gianoukakis, Stephanie L Lee, Joshua P Klopper, Jacqueline T Kung, Mark A Lupo, David Morgenstern, Cristina Prat-Knoll, Andre Sch...> ;Journal of the Endocrine Society. 2023 Aug 1
• 3 citations
  Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatin...
  Matthew H Taylor, Sophie Leboulleux, Yury Panaseykin, Bhavana Konda, Christelle de La Fouchardiere, Brett G M Hughes, Andrew G Gianoukakis, Young Joo Park, Ilia Romano...> ;Cancer Medicine. 2023 Feb 1
• An Assessment of Diversity, Inclusion, and Health Equity Training in Endocrinology Fellowship Programs in the United States.
  Rana Malek, Amal Shibli-Rahhal, Ricardo Correa, Emily D Szmuilowicz, Farah Morgan, Pooja Luthra, Imali Sirisena, Andrew Gianoukakis, Stephanie Smooke Praw, David C Lie...> ;Endocrine Practice. 2022 Nov 1
• 18 citations
  Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).
  Alan L Ho, Marek Dedecjus, Lori J Wirth, R Michael Tuttle, William B Inabnet 3rd, Jan Tennvall, Fernanda Vaisman, Lars Bastholt, Andrew G Gianoukakis, Patrice Rodien, ...> ;Journal of Clinical Oncology. 2022 Jun 10
• 6 citations
  Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer.
  Mohamed A Gouda, Emily Ong, Helen J Huang, Laron W McPhaul, Steve Yoon, Filip Janku, Andrew G Gianoukakis> ;Endocrine. 2022 May 1
• 31 citations
  A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
  Marcia S. Brose, Yury Panaseykin, Bhavana Konda, Christelle De La Fouchardiere, Brett G.M. Hughes, Andrew G. Gianoukakis, Young Joo Park, Ilia Romanov, Monika K. Krzyz...> ;The Journal of Clinical Endocrinology and Metabolism. 2021 Oct 19
• 1 citations
  Graves' disease patients with iron deficiency anemia: serologic evidence of co-existent autoimmune gastritis.
  Andrew G. Gianoukakis, Shelly Gupta, Theresa N Tran, Patrick Richards, Marelle Yehuda, Sarah Tomassetti> ;American Journal of Blood Research. 2021 Jan 1
• 1 citations
  Response to Rosário and Souza Côrtes re: "The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence".
  Ngwe Yin, Steven I. Sherman, Youngju Pak, Danielle R. Litofsky, Andrew G. Gianoukakis> ;Thyroid. 2020 Nov 5
• 11 citations
  The de Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence
  Ngwe Yin, Steven I. Sherman, Youngju Pak, Danielle R. Litofsky, Andrew G. Gianoukakis> ;Thyroid. 2020 May 7
• Voluntary Adoption of an All In Match Policy in the Medical Specialties Matching Program: Advantages and Disadvantages
  Christopher R. McCartney, Andrew G. Gianoukakis, Geetha Gopalakrishnan, Janet B. McGill, Paris Roach, Elias S. Siraj, Mark W. True> ;Journal of Graduate Medical Education. 2019 Aug 1
• Endothelial Cell Growth Promoting Activity in Graves' Disease Sera is Neutralized by Anti-Basic Fibroblast Growth Factor Antibodies in Patients with Fat Expansive but ...
  Mark B Zimering, John J Shin, Jennifer D Zaitz, Elkin A Nunez, Andrew G. Gianoukakis> ;Endocrinology, Diabetes and Metabolism Journal. 2019 Jan 8
• 56 citations
  Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer.
  Makoto Tahara, Marcia S. Brose, Lori J. Wirth, Takuya Suzuki, Hideaki Miyagishi, Katsuki Fujino, Corina E. Dutcus, Andrew G. Gianoukakis> ;European Journal of Cancer. 2019 Jan 1
• 45 citations
  Prolonged duration of response in lenvatinib responders with thyroid cancer.
  Andrew G. Gianoukakis, Corina E. Dutcus, Nicolas Batty, Matthew Guo, Mahadi Ali Baig> ;Endocrine-Related Cancer. 2018 Jun 1
• 14 citations
  Parity and Risk of Thyroid Autoimmunity Based on the NHANES (2001-2002, 2007-2008, 2009-2010, and 2011-2012).
  Marelle Yehuda, Chia-Hao Wang, Youngju Pak, Ken C. Chiu, Andrew G. Gianoukakis> ;The Journal of Clinical Endocrinology and Metabolism. 2017 Sep 1
• 23 citations
  Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm.
  Uzma Haider, Patrick Richards, Andrew G. Gianoukakis> ;Thyroid. 2017 Aug 1
• 70 citations
  Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes.
  Robert I. Haddad, Martin Schlumberger, Lori J. Wirth, Eric J. Sherman, Manisha H. Shah, Bruce G. Robinson, Corina E. Dutcus, Angela Teng, Andrew G. Gianoukakis, Steven...> ;Endocrine. 2017 Feb 3
• 5 citations
  A Cervical Schwannoma Masquerading as a Thyroid Nodule.
  Sravanthi Nagavalli, Marelle Yehuda, Laron McPhaul, Andrew G. Gianoukakis> ;European Thyroid Journal. 2017 Jan 21
• 5 citations
  Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer
  Andrew G. Gianoukakis, Natalia M. Flores, C Pelletier, Anna Forsythe, Gregory R Wolfe, Matthew H. Taylor> ;Cancer Management and Research. 2016 May 30
• 1115 citations
  Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
  Martin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce G. Robinson, Marcia S. Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H. Shah, Ana O. Hof...> ;The New England Journal of Medicine. 2015 Feb 11
• 11 citations
  Thyroglobulin antibody status and differentiated thyroid cancer: what does it mean for prognosis and surveillance?
  Andrew G. Gianoukakis> ;Current Opinion in Oncology. 2015 Jan 1
• Treatment Patterns and Health Outcomes Among Patients with Radioiodine-Refractory Differentiated Thyroid Cancer in the United States and Western Europe.
  Andrew G. Gianoukakis, Natalia M. Flores, C Pelletier, Marco DiBonaventura, Anna Forsythe, Greg Wolfe, Jessicca Rege, Matthew H. Taylor> ;Value in Health. 2014 Nov 1
• 1 citations
  Computer Modeling of a Newly Identified THRB Gene Mutation (S350L) Associated with Resistance to Thyroid Hormone in Three Unrelated Patients
  Sravanthi Nagavalli, Robert J. Fletterick, George Ford, Bruce A. Boston, Andrew G. Gianoukakis> ;Thyroid. 2014 Aug 28
• 20 citations
  Familial adenomatous polyposis-associated, cribriform morular variant of papillary thyroid carcinoma harboring a K-RAS mutation: case presentation and review of molecu...
  Silvana M. Giannelli, Laron McPhaul, Jon Nakamoto, Andrew G. Gianoukakis> ;Thyroid. 2014 Jul 3
• Elephantiatic dermopathy: Elephantiatic dermopathy
  Paul Madaj, Laron McPhaul, Andrew G. Gianoukakis> ;International Journal of Dermatology. 2013 Aug 1
• Join now to see all

Lectures

• Introductory Hands-on Thyroid Ultrasound Workshop 
  ENDO 2019 - New Orleans, LA - 3/22/2019